A Hong Kong company specialised in producing drugs for cancer treatment has been granted financial support from the government to set up its production line in the city’s science park under a scheme to accelerate new industrialisation.
Advanced Isotopes Technology Asia announced on Tuesday that it would invest HK$600 million (US$77.12 million) to set up three production lines at Tai Po InnoPark, under the Hong Kong Science and Technology Parks Corporation (HKSTP), with around HK$140 million…